Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Archives of General Surgery(Electronic Edition) ›› 2013, Vol. 07 ›› Issue (04): 269-272. doi: 10.3877/cma.j.issn.1674-0793.2013.04.007

Special Issue:

• Original Article • Previous Articles     Next Articles

Effects of Ulinastatin in treatment of invasive Candida infections

Xiao-yue LI1, Shun-wei HUANG2, Juan CHEN2, Zhi-yi JIANG2, Xiang-dong GUAN2,()   

  1. 1. Department of Intensive Care Unit, Dongguan People's Hospital, Dongguan 523059, China
  • Received:2012-12-22 Online:2013-08-01 Published:2013-08-01
  • Contact: Xiang-dong GUAN
  • About author:
    Corresponding author: GUAN Xiang-dong, Email:

Abstract:

Objective

To investigate the effects and mechanism of Ulinastatin(UTI) combined with antifungal agents in treatment of invasive Candida infections (ICI).

Methods

Sixty Kunming mice were randomly assigned to control group, low-dose group and high-dose group (20 in each group). The model of ICI was reproduced by intraperitoneal injection of White monilial suspension after CTX pretreatment. Mice in control group were treated with antifungal agents. Mice in low-dose group and high-dose group were treated with UTI (1×104 U/kg or 5×104 U/kg) and antifungal agents. Survival rate, cytokine in liver tissue and blood lymphocyte subsets were compared among these groups.

Results

There was significant difference in survival rate between control group (30%) and high-dose group (70%), P =0.011. There was no significant difference in survival rate between other groups. There were significant differences in IL-10 among three groups, P < 0.05. There were significant differences in CD3+ rate, CD4+ rate and CD8+ rate between control group and high-dose group, P < 0.05. There were significant differences in CD4+/CD8+ rate among three groups, P < 0.05.

Conclusion

High-dose UTI can improve survival rate in mice with ICI through improving cellular immune and reducing immunosuppression.

Key words: Invasive Candida infections, Ulinastatin, Effectiveness

京ICP 备07035254号-20
Copyright © Chinese Archives of General Surgery(Electronic Edition), All Rights Reserved.
Tel: 020-87331056 E-mail: pwwxcma2007@126.com
Powered by Beijing Magtech Co. Ltd